In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I). NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I).

AIDS Res Hum Retroviruses. 1992 Nov;8(11):1845-9. Unique Identifier : AIDSLINE MED/93143992
Koralnik IJ; Lemp JF Jr; Gallo RC; Franchini G; Laboratory of Tumor Cell Biology, National Cancer Institute,; National Institutes of Health, Bethesda, MD 20892.


Abstract: HTLV-I is associated with a neurological syndrome designated Tropical Spastic Paraparesis/HTLV-I associated myelopathy (TSP/HAM). To determine whether HTLV-I can replicate in human primary macrophages and thus contribute to HTLV-I dissemination in the nervous system, elutriated human macrophages were infected cell-free with the HTLV-ICR and HTLV-IBOU isolates from patients with adult T-cell leukemia and TSP/HAM, respectively. Viral production was monitored by measuring the viral p24 gag antigen in the cell culture supernatant, by electron microscopy (EM) and by polymerase chain reaction (PCR) on viral DNA and RNA. The HTLV-I p24 gag antigen was detected 21 days after infection with either isolate, and the presence of mature viral particles was demonstrated by electron microscopy one month after infection. Viral sequences were amplified by PCR analysis of the infected macrophages' DNA. Spliced mRNAs for the p40tax and p27rex proteins, as well as the p12I, and p30II proteins encoded by the pX region were readily identified by reverse transcriptase PCR. Altogether, these data indicate that HTLV-I replication occurs in vitro in primary human macrophages. Whether macrophage infection occurs also in vivo and is a crucial step in the induction of the neurological manifestations observed in TSP/HAM remains an open question.
Keywords: Base Sequence DNA, Viral/ANALYSIS Human HIV Core Protein p24/ANALYSIS HTLV-I/*GROWTH & DEVELOPMENT Leukemia, T-Cell/MICROBIOLOGY Macrophages/*MICROBIOLOGY/PATHOLOGY Molecular Sequence Data Paraparesis, Tropical Spastic/MICROBIOLOGY Polymerase Chain Reaction RNA Splicing RNA, Messenger/ANALYSIS RNA, Viral/ANALYSIS Support, Non-U.S. Gov't Virus Replication JOURNAL ARTICLEKWDbasesequencedna,viral/analysishumanhivcoreproteinp24/analysishtlv-i/KWDgrowth&developmentleukemia,t-cell/microbiologymacrophages/KWDmicrobiology/pathologymolecularsequencedataparaparesis,tropicalspastic/microbiologypolymerasechainreactionrnasplicingrna,messenger/analysisrna,viral/analysissupport,non-uKWDsKWDgov'tvirusreplicationjournalarticle
930530
M9350975

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .